Cortical Mechanisms in Lewy Body Dementia
Cortical Mechanisms in Lewy Body Dementia
批准号:
10188658
负责人:
Georgina Aldridge
金额:
$18.82万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-18 至 2023-06-30
关键词:
AffectAgeAnatomyAnimalsApplications GrantsAreaAxonBrain DiseasesBrain StemCalciumCaregiver BurdenCellsCephalicCharacteristicsComputer AnalysisConsciousDataDementiaDementia with Lewy BodiesDendritesDendritic SpinesDepositionDevelopmentDiffuseDiseaseEducational workshopEvaluationFamilial diseaseFunctional disorderHallucinationsHomeostasisHumanImageIncidenceIndividualInjectionsInstitutionInstructionK-Series Research Career ProgramsKnowledgeLeadLewy BodiesLewy Body DementiaLewy Body DiseaseLewy neuritesLinkLiteratureMeasuresMediatingMental DepressionMentorsMentorshipModelingMonitorMusN-MethylaspartateNMDA receptor antagonistNeurodegenerative DisordersNeuronal DysfunctionNeuronsParkinson&aposs DementiaPathologicPathologic ProcessesPathologyPatientsPhysiciansPopulationPrefrontal CortexPrevalencePropertyProteinsRegulationResearchResourcesRoleScientistSecondary toSleep disturbancesSocietiesStructureSynapsesTechniquesTestingThinnessTimeTrainingVertebral columnViralVisual HallucinationWorkalpha synucleinawakebasecareercareer developmentcraniumdensitydisabilityexperiencefallshuman diseasein vivoin vivo calcium imaginginsightnetwork dysfunctionneuron lossneuronal circuitrynoveloverexpressionprotein functionserial imagingskillssleep abnormalitiessuccesstraining opportunitytwo photon microscopytwo-photon
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Lewy Body dementias are a common form of degenerative dementia. These diseases are debilitating, causing
visual hallucinations, fluctuations in consciousness, disturbed sleep, falls, and depression, all leading to loss of
independence, disability and significant caregiver burden. In these disorders, the protein alpha-synuclein
accumulates into pathognomonic “Lewy bodies” and “Lewy neurites”. Patients with Lewy Body dementia have
diffuse intracellular cortical Lewy Bodies, cortical thinning, and loss of neuronal anatomy, including dendrites
and spines. These changes may occur due to altered calcium regulation caused by alpha-synuclein oligomers,
which accumulate under pathologic conditions. Overexpression of alpha-synuclein in humans leads to familial
disease, including dementia, and therefore provides a useful model to evaluate the mechanisms of neuronal
dysfunction. This proposal uses viral overexpression of alpha-synuclein in the cortex of mice to examine the
pathological changes occurring in cortical neurons as the protein accumulates. Specifically, this proposal first
tests the hypothesis that local alpha-synuclein accumulation induces dendritic spine instability, leading to
dendritic spine loss overtime. This is tested using longitudinal, live animal, 2-photon imaging to repeatedly
observe individual dendritic spines as pathology develops. Secondly, this proposal evaluates if calcium
dynamics change over time due to alpha-synuclein accumulation, a potential mechanism for network
dysfunction and anatomical pathology. The findings from this proposal will demonstrate how a-synuclein exerts
its pathological effect in cortical cells and evaluate a mechanistic model based on Ca2+ dynamics. By including
evaluation over time, these studies are more likely to model aspects of human disease and lead to translatable
treatments. As a career development grant this proposal is ideal; it leverages the applicant’s past skills in 2-
photon imaging of dendritic spines with a complementary, mechanistic and computational approach using Ca2+
imaging, which is novel to the applicant. The institution is dedicated to providing the support and resources
necessary for the applicant’s success. There is strong mentorship available in areas of research proposed,
supplemented with instruction by consultants and formal workshops. Together, this will provide key training
opportunities that will advance the applicant’s career as an academic physician-scientist focusing on
understanding and treating Lewy Body Dementias.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cortical Alpha-Synuclein in Dementia
-
批准号:10563300
-
项目类别:
-
资助金额:$59.08万
-
财政年份:2023
-
负责人:Georgina Aldridge
-
依托单位:
Cellular mechanisms in rodent prefrontal cortex
-
批准号:10490437
-
项目类别:
-
资助金额:$8.83万
-
财政年份:2021
-
负责人:Georgina Aldridge
-
依托单位:
Cellular mechanisms in rodent prefrontal cortex
-
批准号:10283243
-
项目类别:
-
资助金额:$11.18万
-
财政年份:2021
-
负责人:Georgina Aldridge
-
依托单位:
Cortical Mechanisms in Lewy Body Dementia
-
批准号:9976607
-
项目类别:
-
资助金额:$18.72万
-
财政年份:2018
-
负责人:Georgina Aldridge
-
依托单位:
Cortical Mechanisms in Lewy Body Dementia
-
批准号:10409753
-
项目类别:
-
资助金额:$18.72万
-
财政年份:2018
-
负责人:Georgina Aldridge
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: